UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Enhancement of the Therapeutic Index: From Nonmyeloablative and Myeloablative toward Pretargeted Radioimmunotherapy for Metastatic Prostate Cancer

Clinical cancer research, 2005-10, Vol.11 (19), p.7187s-7194s

2005

Volltextzugriff (PDF)

Acetaminophen and diphenhydramine as premedication for platelet transfusions: A prospective randomized double‐blind placebo‐controlled trial

American journal of hematology, 2002-07, Vol.70 (3), p.191-194

2002

Volltextzugriff (PDF)

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Dyskeratosis Congenita

Biology of blood and marrow transplantation, 2013-08, Vol.19 (8), p.1238-1243

2013

Volltextzugriff (PDF)

The Addition of Ibritumomab Tiuxetan (IT) to the ATG/TLI Preparative Regimen Is Safe and May Enhance Post-Transplant Response and Outcomes for Patients with Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

Blood, 2019-11, Vol.134 (Supplement_1), p.3334-3334

2019

Volltextzugriff (PDF)

Comparison of normal tissue pharmacokinetics with 111In/ 90Y monoclonal antibody m170 for breast and prostate cancer

International journal of radiation oncology, biology, physics, 2006-11, Vol.66 (4), p.1192-1198

2006

Volltextzugriff (PDF)

Enhanced therapeutic index of radioimmunotherapy (RIT) in prostate cancer patients: comparison of radiation dosimetry for 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA)-peptide versus 2IT-DOTA monoclonal antibody linkage for RIT

Clinical cancer research, 2003-09, Vol.9 (10 Pt 2), p.3938S-44S

2003

Volltextzugriff (PDF)

Planning Time for Peripheral Blood Stem Cell Infusion After High-Dose Targeted Radionuclide Therapy Using Dosimetry

The Journal of nuclear medicine (1978), 2005-06, Vol.46 (6), p.1034-1041

2005

Volltextzugriff (PDF)

Acute myocardial infarction in hemoglobin SC disease

Annals of hematology, 2004-10, Vol.83 (10), p.622-624

2004

Volltextzugriff (PDF)

Strategies for Developing Effective Radioimmunotherapy for Solid Tumors

Clinical cancer research, 1999-10, Vol.5 (10), p.3219s-3223s

1999

Volltextzugriff (PDF)

Radioimmunotherapy with 111In/90Y-2IT-BAD-m170 for Metastatic Prostate Cancer

Clinical cancer research, 2001-06, Vol.7 (6), p.1561-1568

2001

Volltextzugriff (PDF)

OUTCOMES OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT IN PATIENTS WITH DYSKERATOSIS CONGENITA

Biology of blood and marrow transplantation, 2013-06, Vol.19 (8), p.1238-1243

2013

Volltextzugriff (PDF)

Intensive Care Unit Admissions in Patients with Hematologic Malignancies: Outcomes and Prognostic Indicators

Blood, 2005-11, Vol.106 (11), p.752-752

2005

Volltextzugriff (PDF)

Reduced Intensity Stem Cell Transplant (RIST) as Salvage Treatment for Relapse Following Myeloablative Allogeneic Transplantation in Adult Acute Myeloid Leukemia

Blood, 2006-11, Vol.108 (11), p.5374-5374

2006

Volltextzugriff (PDF)

Comparison of normal tissue pharmacokinetics with {sup 111}In/{sup 9}Y monoclonal antibody m170 for breast and prostate cancer

International journal of radiation oncology, biology, physics, 2006-11, Vol.66 (4)

2006

Volltextzugriff (PDF)

Systemic radiotherapy in metastatic breast cancer using 90Y-linked monoclonal MUC-1 antibodies : The promise of monoclonal antibodies for the therapy of cancer

Critical reviews in oncology/hematology, 2001, Vol.38 (1), p.25-35

2001

Volltextzugriff (PDF)

Yttrium-90/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer

Anticancer research, 1997-05, Vol.17 (3B), p.1735

1997

Volltextzugriff (PDF)

High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to lndium-111 /yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human anti-mouse antibody

Clinical cancer research, 2005, Vol.11 (16), p.5920-5927

2005

Volltextzugriff (PDF)

Systemic radiotherapy in metastatic breast cancer using 90Y-linked monoclonal MUC-1 antibodies

Critical reviews in oncology/hematology, 2001-04, Vol.38 (1), p.25-35

2001

Volltextzugriff (PDF)

Enhanced Therapeutic Index of Radioimmunotherapy (RIT) in Prostate Cancer Patients

Clinical cancer research, 2003-09, Vol.9 (10), p.3938s

2003

Volltextzugriff (PDF)

Importance of temporal relationships in combined modality radioimmunotherapy of breast carcinoma

Cancer, 1997-12, Vol.80 (S12), p.2583-2590

1997

Volltextzugriff (PDF)

Group psychotherapy with the elderly: Problems and prospects

Psychotherapy (Chicago, Ill.), 1982, Vol.19 (4), p.437-443

1982

Volltextzugriff (PDF)

Enhancement of the therapeutic index : From non myeloablative and myeloablative toward pretargeted radioimmunotherapy for metastatic prostate cancer

Clinical cancer research, 2005, Vol.11 (19), p.7187s-7194s

2005

Volltextzugriff (PDF)

Radioimmunotherapy for Breast Cancer Using Indium-lll/Yttrium-90 BrE-3: Results of a Phase I Clinical Trial

The Journal of nuclear medicine (1978), 1997-08, Vol.38 (8), p.1180

1997

Volltextzugriff (PDF)

Radioimmunotherapy for breast cancer using escalating fractionated doses of 131I-labeled chimeric L6 antibody with peripheral blood progenitor cell transfusions

Cancer research (Chicago, Ill.), 1995-12, Vol.55 (23 Suppl), p.5916s

1995

Volltextzugriff (PDF)

Granulocyte/Macrophage Progenitor Cells From Peripheral Blood and Bone Ma rrow Differ in Their Response to Prostaglandin E1

Blood, 1987-12, Vol.70 (6), p.1792-1796

1987

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(60)

Publikationsform

Sprache

Englisch
(68)
Ungarisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(37)
Humans
(35)
Female
(18)
Biological And Medical Sciences
(16)
Animals
(13)
Male
(13)
Medical Sciences
(11)
Oncology
(9)
Hematology
(8)
Radioimmunotherapy
(8)
Pharmacology. Drug Treatments
(7)
Antineoplastic Agents
(6)
Mice
(6)
Adult
(5)
Antibodies, Monoclonal - Therapeutic Use
(5)
Fundamental And Applied Biological Sciences. Psychology
(5)
Immunology
(5)
Yttrium Radioisotopes - Therapeutic Use
(5)
Child
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Enhancement of the Therapeutic Index: From Nonmyeloablative and Myeloablative toward Pretargeted Radioimmunotherapy for Metastatic Prostate Cancer

Acetaminophen and diphenhydramine as premedication for platelet transfusions: A prospective randomized double‐blind placebo‐controlled trial

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Dyskeratosis Congenita

The Addition of Ibritumomab Tiuxetan (IT) to the ATG/TLI Preparative Regimen Is Safe and May Enhance Post-Transplant Response and Outcomes for Patients with Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

Comparison of normal tissue pharmacokinetics with 111In/ 90Y monoclonal antibody m170 for breast and prostate cancer

Enhanced therapeutic index of radioimmunotherapy (RIT) in prostate cancer patients: comparison of radiation dosimetry for 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA)-peptide versus 2IT-DOTA monoclonal antibody linkage for RIT

Planning Time for Peripheral Blood Stem Cell Infusion After High-Dose Targeted Radionuclide Therapy Using Dosimetry

Acute myocardial infarction in hemoglobin SC disease

Strategies for Developing Effective Radioimmunotherapy for Solid Tumors

Radioimmunotherapy with 111In/90Y-2IT-BAD-m170 for Metastatic Prostate Cancer

OUTCOMES OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT IN PATIENTS WITH DYSKERATOSIS CONGENITA

Intensive Care Unit Admissions in Patients with Hematologic Malignancies: Outcomes and Prognostic Indicators

Reduced Intensity Stem Cell Transplant (RIST) as Salvage Treatment for Relapse Following Myeloablative Allogeneic Transplantation in Adult Acute Myeloid Leukemia

Comparison of normal tissue pharmacokinetics with {sup 111}In/{sup 9}Y monoclonal antibody m170 for breast and prostate cancer

Systemic radiotherapy in metastatic breast cancer using 90Y-linked monoclonal MUC-1 antibodies : The promise of monoclonal antibodies for the therapy of cancer

Yttrium-90/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer

High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to lndium-111 /yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human anti-mouse antibody

Systemic radiotherapy in metastatic breast cancer using 90Y-linked monoclonal MUC-1 antibodies

Enhanced Therapeutic Index of Radioimmunotherapy (RIT) in Prostate Cancer Patients

Importance of temporal relationships in combined modality radioimmunotherapy of breast carcinoma

Group psychotherapy with the elderly: Problems and prospects

Enhancement of the therapeutic index : From non myeloablative and myeloablative toward pretargeted radioimmunotherapy for metastatic prostate cancer

Radioimmunotherapy for Breast Cancer Using Indium-lll/Yttrium-90 BrE-3: Results of a Phase I Clinical Trial

Radioimmunotherapy for breast cancer using escalating fractionated doses of 131I-labeled chimeric L6 antibody with peripheral blood progenitor cell transfusions

Granulocyte/Macrophage Progenitor Cells From Peripheral Blood and Bone Ma rrow Differ in Their Response to Prostaglandin E1

Aktive Filter

Suchergebnisse filtern